ProShares UltraShort Nasdaq Biotechnology (BIS)
| Assets | $3.00M |
| Expense Ratio | 0.95% |
| PE Ratio | n/a |
| Shares Out | 151,096 |
| Dividend (ttm) | $0.65 |
| Dividend Yield | 3.58% |
| Ex-Dividend Date | Mar 26, 2025 |
| Payout Ratio | n/a |
| 1-Year Return | +3.64% |
| Volume | 21,698 |
| Open | 18.58 |
| Previous Close | 18.81 |
| Day's Range | 18.20 - 18.81 |
| 52-Week Low | 14.05 |
| 52-Week High | 25.87 |
| Beta | -1.32 |
| Holdings | 7 |
| Inception Date | Apr 8, 2010 |
About BIS
Fund Home PageThe ProShares UltraShort Nasdaq Biotechnology (BIS) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index. The fund provides -2x exposure to a market-cap-weighted index of biotechnology and pharmaceutical companies listed on the NASDAQ. BIS was launched on Apr 8, 2010 and is issued by ProShares.
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Mar 26, 2025 | $0.13255 | Apr 1, 2025 |
| Dec 23, 2024 | $0.20639 | Dec 31, 2024 |
| Sep 25, 2024 | $0.15181 | Oct 2, 2024 |
| Jun 26, 2024 | $0.16119 | Jul 3, 2024 |
| Mar 20, 2024 | $0.15859 | Mar 27, 2024 |
| Dec 20, 2023 | $0.17591 | Dec 28, 2023 |
News
Top Performing Leveraged/Inverse ETFs: 05/11/2025
Top Performing Leveraged/Inverse ETFs Last Week These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
Seeking Stocks With Vitality In The Volatile Healthcare Sector
Investors cooled to the healthcare sector in 2024, which dramatically trailed global and US equity markets for the year. any investors are now asking: how will the policy changes under a new US admini...
Purchase Levels Of 31 Short ETFs Signal Bear Market Bottom (Technical Analysis)
We are bearish on all American bear market ETFs. Measuring the purchase levels of short ETFs replaces the old, odd lot and total short selling indicators so popular in the 1960s, 70s and 80s.